HIF1A and small cell lung carcinoma: Several studies have analyzed transcriptomics in paired biopsies from patients who were treated with chemotherapy and have identified PI3K/AKT, HIF-1, MYC, and TGF-β pathways as potential mediators of acquired resistance, but similar studies in immunotherapy or chemoimmunotherapy are sparse in SCLC[82,125,126].